Cargando…

Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine

BACKGROUND: Many cancer patients undergo sophisticated laboratory testing, which requires proper interpretation and interaction between different specialists. CASE PRESENTATION: We describe a patient with an extensive family history of cancer, who was diagnosed with bilateral breast cancer and two l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sokolova, Tatiana N., Breder, Valeriy V., Shumskaya, Irina S., Suspitsin, Evgeny N., Aleksakhina, Svetlana N., Yanus, Grigoriy A., Tiurin, Vladislav I., Ivantsov, Alexandr O., Vona, Barbara, Raskin, Grigoriy A., Gamajunov, Sergey V., Imyanitov, Evgeny N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789132/ https://www.ncbi.nlm.nih.gov/pubmed/33407806 http://dx.doi.org/10.1186/s13053-020-00157-8

Ejemplares similares

Hereditary cancer syndromes
por: Imyanitov, Evgeny N, et al.
Publicado: (2023)

Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1
por: Mitiushkina, Natalia V., et al.
Publicado: (2022)

Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study
por: Orlov, Sergey V., et al.
Publicado: (2021)

Harmonization of Molecular Testing for Non-Small Cell Lung Cancer: Emphasis on PD-L1
por: Imyanitov, Evgeny N., et al.
Publicado: (2020)

Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I
por: Orlova, Kristina V., et al.
Publicado: (2019)

Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives
por: Aleksakhina, Svetlana N., et al.
Publicado: (2021)

Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer
por: Mitiushkina, Natalia V., et al.
Publicado: (2022)

Tumor irradiation may facilitate the detection of tumor-specific mutations in plasma
por: Kuligina, Ekaterina, et al.
Publicado: (2021)

Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas
por: Tiurin, Vladislav I., et al.
Publicado: (2023)

Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples
por: Romanko, Aleksandr A., et al.
Publicado: (2023)

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer
por: Moiseyenko, Fedor V., et al.
Publicado: (2022)

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas
por: Martianov, Aleksandr S., et al.
Publicado: (2023)

Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
por: Gorodnova, Tatiana V., et al.
Publicado: (2021)

CHEK2 1100 delC mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2007)

Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation
por: Moiseyenko, Fedor V., et al.
Publicado: (2019)

Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab
por: Orlov, Sergey V., et al.
Publicado: (2020)

Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
por: Imyanitov, Evgeny N
Publicado: (2009)

Systemic therapy for hereditary cancer
por: Imyanitov, Evgeny N
Publicado: (2012)

Cytotoxic and targeted therapy for BRCA1/2-driven cancers
por: Imyanitov, Evgeny N.
Publicado: (2021)

Erroneous
Publicado: (1883)

Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer
por: Sokolenko, Anna P., et al.
Publicado: (2022)

Molecular Analysis of Biliary Tract Cancers with the Custom 3′ RACE-Based NGS Panel
por: Mitiushkina, Natalia V., et al.
Publicado: (2023)

6-(Tetrazol-5-yl)-7-aminoazolo[1,5-a]pyrimidines as Novel Potent CK2 Inhibitors
por: Urakov, Grigoriy V., et al.
Publicado: (2022)

Systemic treatment for hereditary cancers: a 2012 update
por: Imyanitov, Evgeny N, et al.
Publicado: (2013)

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
por: Suspitsin, Evgeny N, et al.
Publicado: (2009)

An Erroneous Diagnosis
Publicado: (1898)

Drug therapy for hereditary cancers
por: Imyanitov, Evgeny N, et al.
Publicado: (2011)

Cytotoxic and targeted therapy for hereditary cancers
por: Iyevleva, Aglaya G., et al.
Publicado: (2016)

Molecular Diagnostics in Clinical Oncology
por: Sokolenko, Anna P., et al.
Publicado: (2018)

MISINTERPRETER OF MALADIES !
por: Andrade, Chittaranjan
Publicado: (2000)

Platinum drugs and taxanes: can we overcome resistance?
por: Sazonova, Elena V., et al.
Publicado: (2021)

False-positive antibody signals for the pluripotency factor OCT4A (POU5F1) in testis-derived cells may lead to erroneous data and misinterpretations
por: Warthemann, R., et al.
Publicado: (2012)

The first documentation of Li-Fraumeni syndrome in Korea.
por: Bang, Y. J., et al.
Publicado: (1995)

Pediatric Case of Li–Fraumeni Syndrome in Honduras
por: Martínez-Beckerat, R., et al.
Publicado: (2021)

Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017)

Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing
por: Sokolenko, Anna P, et al.
Publicado: (2009)

ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers
por: Mulkidjan, Rimma S., et al.
Publicado: (2023)

Simultaneous Onset of Pediatric Systemic Lupus Erythematosus in Twin Brothers: Case Report
por: Raupov, Rinat K., et al.
Publicado: (2022)

Your erroneous zones
por: Dyer, Wayne D
Publicado: (1976)

Continued misinterpretation of confidence intervals: response to Miller and Ulrich
por: Morey, Richard D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2ursr7r9k62im312l0nf844qe2